Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0522-2020Class II

HENNESSY LEFT CONST GLENOID HA, Item No. PM555360 UDI (01)00880304819597(17)260425(10)664030

Zimmer GmbH / initiated 2019-08-21 / Terminated / root cause: manufacturing process

Zimmer Biomet, Inc. began a recall of HENNESSY LEFT CONST GLENOID HA, Item No. PM555360 UDI (01)00880304819597(17)260425(10)664030 Product Usage: Constrained Shoulder on . FDA classified it as Class II and gives the reason as "Elevated levels of bacterial endotoxin and residual debris remain on the devices due to cleaning issue". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0522-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Zimmer GmbH
Product
HENNESSY LEFT CONST GLENOID HA, Item No. PM555360 UDI (01)00880304819597(17)260425(10)664030 Product Usage: Constrained Shoulder.
Product code
NA
Reason for recall
Elevated levels of bacterial endotoxin and residual debris remain on the devices due to cleaning issue.
Root cause tag
manufacturing process
FDA root cause
Environmental control
Action
On September 11, 2019, the firm began notifying distributors and customers of the recall via an Urgent Medical Device Recall letter. The letter informed consignees of the product issue. Customers were asked to assist their Zimmer Biomet sales representative and quarantine all identified product. The sales representative will remove the product from your facility. If any products were further distributed, please forward the notification to responsible parties. If you have further questions or concerns, please call customer service at 574-371-3071 between 8:00 am and 5:00 pm ET, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to [email protected]. There are no specific patient monitoring instructions related to this recall that are recommended beyond your existing follow-up schedule.
Quantity in commerce
219988 units (total)
Distribution
US Nationwide distribution and countries of Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Italy, Netherlands, India, Japan, Korea, Malaysia, Mexico, New Zealand, Panama, Singapore, Taiwan, Thailand, Trinidad and Tobago, and Venezuela.
Product codes and lots
664030

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0522-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0519-2020Class IITerminatedVoluntary: Firm initiated
Z-0520-2020Class IITerminatedVoluntary: Firm initiated
Z-0521-2020Class IITerminatedVoluntary: Firm initiated
Z-0522-2020Class IITerminatedVoluntary: Firm initiated
Z-0523-2020Class IITerminatedVoluntary: Firm initiated
Z-0524-2020Class IITerminatedVoluntary: Firm initiated
Z-0525-2020Class IITerminatedVoluntary: Firm initiated
Z-0526-2020Class IITerminatedVoluntary: Firm initiated
Z-0527-2020Class IITerminatedVoluntary: Firm initiated
Z-0528-2020Class IITerminatedVoluntary: Firm initiated
Z-0529-2020Class IITerminatedVoluntary: Firm initiated
Z-0530-2020Class IITerminatedVoluntary: Firm initiated
Z-0531-2020Class IITerminatedVoluntary: Firm initiated
Z-0532-2020Class IITerminatedVoluntary: Firm initiated
Z-0533-2020Class IITerminatedVoluntary: Firm initiated